| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.76 | 2e-08 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |